The Dublin-based, London-listed company said Xiidra is available as a twice daily eye drop for signs and symptoms ... Perry Sternberg, Shire's US commercial head, said: “Shire worked rapidly ...
Novartis paid Takeda $3.4 billion for its FDA-approved dry eye drug Xiidra during the Japanese ... FDA approval of a phase 3 trial for eye drops containing tivanisiran, in dry eye disease associat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback